138 related articles for article (PubMed ID: 35014432)
1. Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy.
Chen M; Xu X; Shu G; Lu C; Wu J; Lv X; Song J; Wu F; Chen C; Zhang N; Du Y; Wang J; Xu M; Fang S; Weng Q; Zhu Y; Huang Y; Zhao Z; Du Y; Ji J
ACS Appl Bio Mater; 2021 Apr; 4(4):3476-3489. PubMed ID: 35014432
[TBL] [Abstract][Full Text] [Related]
2. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin Intracellular Release
El Founi M; Laroui H; Canup BSB; Ametepe JS; Vanderesse R; Acherar S; Babin J; Ferji K; Chevalot I; Six JL
ACS Appl Bio Mater; 2021 Mar; 4(3):2742-2751. PubMed ID: 35014313
[TBL] [Abstract][Full Text] [Related]
4. Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy.
Zhang Y; Wei C; Lv F; Liu T
Colloids Surf B Biointerfaces; 2018 Oct; 170():163-171. PubMed ID: 29906701
[TBL] [Abstract][Full Text] [Related]
5. Monodisperse CaCO
Chen M; Guo X; Shen L; Ding J; Yu J; Chen X; Wu F; Tu J; Zhao Z; Nakajima M; Song J; Shu G; Ji J
Int J Biol Macromol; 2023 Mar; 231():123160. PubMed ID: 36610575
[TBL] [Abstract][Full Text] [Related]
6. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
Duan W; Liu Y
Drug Des Devel Ther; 2018; 12():2149-2161. PubMed ID: 30034219
[TBL] [Abstract][Full Text] [Related]
7. Embedding fluorescent mesoporous silica nanoparticles into biocompatible nanogels for tumor cell imaging and thermo/pH-sensitive in vitro drug release.
Gui R; Wang Y; Sun J
Colloids Surf B Biointerfaces; 2014 Apr; 116():518-25. PubMed ID: 24576821
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor.
Meng M; Gao J; Wu C; Zhou X; Zang X; Lin X; Liu H; Wang C; Su H; Liu K; Wang Y; Xue X; Wu J
Tumour Biol; 2016 Jul; 37(7):8673-80. PubMed ID: 26738862
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
[TBL] [Abstract][Full Text] [Related]
10. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
Miao Y; Qiu Y; Yang W; Guo Y; Hou H; Liu Z; Zhao X
Colloids Surf B Biointerfaces; 2018 Sep; 169():313-320. PubMed ID: 29800906
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Carbon Monoxide Prodrug-Loaded Nanoplatforms for Effective Photoacoustic Imaging-Guided Photothermal/Gas Synergistic Therapy.
Lin Y; Zhong W; Wang M; Chen Z; Lu C; Yang H
ACS Appl Bio Mater; 2021 May; 4(5):4557-4564. PubMed ID: 35006792
[TBL] [Abstract][Full Text] [Related]
12. pH-Driven Targeting Nanoprobe with Dual-Responsive Drug Release for Persistent Luminescence Imaging and Chemotherapy of Tumor.
Zhang HJ; Zhao X; Chen LJ; Yang CX; Yan XP
Anal Chem; 2020 Jan; 92(1):1179-1188. PubMed ID: 31818096
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
15. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
16. A drug-loaded nanoscale metal-organic framework with a tumor targeting agent for highly effective hepatoma therapy.
Li YA; Zhao XD; Yin HP; Chen GJ; Yang S; Dong YB
Chem Commun (Camb); 2016 Dec; 52(98):14113-14116. PubMed ID: 27858003
[TBL] [Abstract][Full Text] [Related]
17. PVA reinforced gossypolone and doxorubicin π-π stacking nanoparticles towards tumor targeting and ultralow dose synergistic chemotherapy.
Liu Y; Li K; Wu Y; Ma J; Tang P; Liu Y; Wu D
Biomater Sci; 2019 Aug; 7(9):3662-3674. PubMed ID: 31179466
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.
Melguizo C; Cabeza L; Prados J; Ortiz R; Caba O; Rama AR; Delgado ÁV; Arias JL
Drug Des Devel Ther; 2015; 9():6433-44. PubMed ID: 26715840
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy.
Xia Y; Xiao M; Zhao M; Xu T; Guo M; Wang C; Li Y; Zhu B; Liu H
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110100. PubMed ID: 31753388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
